Lin Zhou

5.1k citations
149 papers · 4.1k indexed · h-index 38
Topics
Bone Metabolism and Diseases (27 papers)MicroRNA in disease regulation (14 papers)Bone health and treatments (12 papers)

In The Last Decade

Lin Zhou

144 papers receiving 4.0k citations

Peers

Lin Zhou
Comparison fields: 5 of 125
  • Molecular Biology 1.9k
  • Oncology 1.2k
  • Immunology 868
  • Cancer Research 840
  • Epidemiology 361
Replace Eli C. Lewis with:
Eli C. Lewis Israel
Bing Xu China
Francesca Zazzeroni Italy
Sara Teresinha Olalla Saad Brazil
Timothy T. Lu United States
Carole Peyssonnaux France
Jongseon Choe South Korea
L. Vijaya Mohan Rao United States
Nelson H. Tsuno Japan
Nancy R. Webb United States
Lin Zhou relative to Eli C. Lewis Israel Eli C. Lewis's profile →
Citations per field
00.5×
Eli C. Lewis · 1×
Citations per year

Countries citing papers authored by Lin Zhou

Since Specialization
Citations

This map shows the geographic impact of Lin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhou more than expected).

Fields of papers citing papers by Lin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhou. The network helps show where Lin Zhou may publish in the future.

Co-authorship network of co-authors of Lin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Zhou. A scholar is included among the top collaborators of Lin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Zhou. Lin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 3
4 1
5 2
6 11
7 12
8 17
9 4
10 7
11 16
12
The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation
1
13 14
14 28
15 18
16 15
17 37
18 18
19 2
20 9

About Lin Zhou

Lin Zhou is a scholar working on Cancer Research, Oncology and Immunology, having authored 149 papers that have together received 4.1k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (27 papers), MicroRNA in disease regulation (14 papers) and Bone health and treatments (12 papers). The work is most often cited by research in Cancer Research (840 citations), Oncology (1.2k citations) and Immunology (868 citations). Lin Zhou has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Qingcheng Mao, Jashvant D. Unadkat, Jiake Xu, Honggang Wang, Jennifer Tickner, Jinmin Zhao, Yulong Shang, Kaichun Wu, Yi Zhang and Anshul Gupta. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026